Please assess the completion status of the following clinical trial:

Trial Title: Improving Labour Induction Analgesia: Epidural Fentanyl Bolus at Epidural Initiation for Induction of Labour

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy parturients~* Parturients presenting for labour induction for post-term pregnancy (i.e. pregnancy beyond 42 weeks gestational age)~* Parturients who have had an uncomplicated pregnancy~Exclusion Criteria:~* Parturients presenting for induction of labour for pre-labour (premature) rupture of membranes~* Parturients presenting for induction of labour for hypertensive disorders of pregnancy \[including preeclampsia, eclampsia, HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets)\]~* Parturients with maternal diabetes~* Fetal growth restriction~* Multiple gestation pregnancy~* Known or suspected Chorioamnionitis~* Known or suspected Abruptio placentae~* Oligohydramnios~* Parturients with cholestasis of pregnancy~* Known alloimmunization with fetal effects.~* Parturients with other chronic medical conditions or any complications related to pregnancy~* Participants who lack capacity to consent on their own behalf

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Control Group (No Additional Epidural Fentanyl Bolus) (Type: ACTIVE_COMPARATOR): The Control group will receive a 2 ml bolus of standard epidural mix solution after epidural placement followed by standard care infusion of epidural local anesthetic/opioids, with a PCEA pump for subsequent analgesia.
- Fentanyl bolus group (Type: EXPERIMENTAL): The Fentanyl bolus group will receive a 2 ml bolus of epidural Fentanyl (50 mcg/ml; therefore a total dose of 100 mcg) after epidural placement, followed by a standard care infusion of epidural local anesthetic/opioids, with a PCEA pump for subsequent analgesia.

Based on this trial design, predict the completion outcome and termination type (if applicable).